Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis

dc.contributor.authorIlhan, F
dc.contributor.authorAkbulut, H
dc.contributor.authorKaraca, I
dc.contributor.authorGodekmerdan, A
dc.contributor.authorIlkay, E
dc.contributor.authorBulut, V
dc.date.accessioned2026-08-12T17:29:04Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description.abstractObjective-Recent studies demonstrate that the serum inflammatory markers increase in patients with atherosclerosis. We aimed to assess whether a difference exists between patients with acute coronary syndrome and patients with stable angina pectoris in respect to serum neopterin, procalcitonin (PCT) and C-reactive protein (CRP) levels. Methods and results-A total of 52 patientss (42 male, 10 female) who had atherosclerosis confirmed by angiography and were being followed up for an acute coronary syndrome were recruited and for control group, 45 patients with stable angina pectoris (SA) (35 male and 10 female) who underwent coronary angiography, were examined. Serum concentrations of neopterin, CRP and PCT in the study group (acute coronary syndrome) were compared to control group (stable angina pectoris).The mean neopterin level of the study group was 22.47 +/- 2.93 nmol/l, the mean CRP level was 30.40 +/- 8.05 mg/l and the mean PCT level was 0.40 +/- 0.04 ng/ml. In control group these levels were 12.26 +/- 0.61 nmol/l (p < 0.05), 5.26 +/- 0.64 mg/l (p < 0.001) and 0.19 +/- 0.02 ng/ml (p < 0.001), respectively. Conclusion-In the presented study our results showed that these markers can be useful for the assessment of inflammation related to atherosclerosis.
dc.identifier.doi10.2143/AC.60.4.2004983
dc.identifier.endpage365
dc.identifier.issn0001-5385
dc.identifier.issn1784-973X
dc.identifier.issue4
dc.identifier.orcid0000-0003-1656-2481
dc.identifier.orcid0000-0002-0508-2127
dc.identifier.orcid0000-0001-7790-1358
dc.identifier.pmid16128367
dc.identifier.scopus2-s2.0-23644445353
dc.identifier.scopusqualityQ3
dc.identifier.startpage361
dc.identifier.urihttps://doi.org/10.2143/AC.60.4.2004983
dc.identifier.urihttps://hdl.handle.net/11508/55554
dc.identifier.volume60
dc.identifier.wosWOS:000231385300002
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofActa Cardiologica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectneopterin
dc.subjectprocalcitonin
dc.subjectC-reactive protein
dc.subjectatherosclerosis
dc.titleProcalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis
dc.typeArticle

Dosyalar